The Merck Access Program for RENFLEXIS® (infliximab-abda)
Please read the Medication Guide for RENFLEXIS, including the information about serious infections and cancers, and discuss it with your doctor. The physician Prescribing Information also is available.

WELCOME TO

THE MERCK ACCESS PROGRAM

ARE YOU A US HEALTH CARE PROFESSIONAL?
YES
NO


THE MERCK CO-PAY ASSISTANCE PROGRAM FOR RENFLEXIS

The Merck Co-pay Assistance Program offers assistance to eligible patients who need help affording RENFLEXIS.
  • Once enrolled, eligible, privately insured patients pay the first $5 of their co-pay per infusion
  • Maximum co-pay assistance program benefit is $20,000 per patient, per calendar year (based on income)

Co-pay assistance from Merck Co-pay Assistance Program is not insurance. Restrictions apply. See Terms and Conditions.

You may be eligible if you
  • Are a resident of the United States (including Puerto Rico)
  • Have private health insurance that provides coverage for RENFLEXIS
  • Have been prescribed RENFLEXIS for an FDA-approved indication
  • Meet financial eligibility requirements as set forth in the Terms and Conditions
  • Meet all other Terms and Conditions of the program
The Merck Co-pay Assistance Program is not valid for patients covered under a Government Program, as that term is defined in the Terms and Conditions. The Merck Co-pay Assistance Program is not valid for uninsured patients.

You and your health care professional must submit all required information. Please see the enrollment form for details.

Other financial support options for RENFLEXIS

What if I am not eligible for the Merck Co-pay Assistance Program?

You may be able to get help from an independent co-pay assistance foundation. A representative can provide you with information about independent foundations that may be able to provide financial support to patients who do not qualify for the Merck Co-pay Assistance Program. Each independent foundation has its own eligibility criteria and application process.

Questions? Contact The Merck Access Program at 866-847-3539 Mon-Fri 8 AM to 8 PM ET to speak to a representative.